Abstract:Background: Cardiac stereotactic body radiotherapy (CSBRT) with photons efficaciously and safely treats cardiovascular arrhythmias. Proton therapy, with its unique physical and radiobiological properties, can offer advantages over traditional photon-based therapies in certain clinical scenarios, particularly pediatric tumors and those in anatomically challenging areas. However, dose uncertainties induced by cardiorespiratory motion are unknown. Objective: This study investigated the effect of cardiorespiratory motion on intensity-modulated proton therapy (IMPT) and the effectiveness of motion-encompassing methods. Methods: We retrospectively included 12 patients with refractory arrhythmia who underwent CSBRT with four-dimensional computed tomography (4DCT) and 4D cardiac CT (4DcCT). Proton plans were simulated using an IBA accelerator based on the 4D average CT. The prescription was 25 Gy in a single fraction, with all plans normalized to ensure that 95% of the target volume received the prescribed dose. 4D dose reconstruction was performed to generate 4D accumulated and dynamic doses. Furthermore, dose uncertainties due to the interplay effect of the substrate target and organs at risk (OARs) were assessed. The differences between internal organs at risk volume (IRV) and OARreal (manually contoured on average CT) were compared. In 4D dynamic dose, meeting prescription requirements entails V25 and D95 reaching 95% and 25 Gy, respectively. Results: The 4D dynamic dose significantly differed from the 3D static dose. The mean V25 and D95 were 89.23% and 24.69 Gy, respectively, in 4DCT and 94.35% and 24.99 Gy, respectively, in 4DcCT. Eleven patients in 4DCT and six in 4DcCT failed to meet the prescription requirements. Critical organs showed varying dose increases. All metrics, except for Dmean and D50, significantly changed in 4DCT; in 4DcCT, only D50 remained unchanged with regards to the target dose uncertainties induced by the interplay effect. The interplay effect was only significant for the Dmax values of several OARs. Generally, respiratory motion caused a more pronounced interplay effect than cardiac pulsation. Neither IRV nor OARreal effectively evaluated the dose discrepancies of the OARs. Conclusions: Complex cardiorespiratory motion can introduce dose uncertainties during IMPT. Motion-encompassing techniques may mitigate but cannot entirely compensate for the dose discrepancies. Individualized 4D dose assessments are recommended to verify the effectiveness and safety of CSBRT.

Experimental investigation of irregular motion impact on 4D PET-based particle therapy monitoring

Experimental Validation of a Real-Time Adaptive 4D-Optimized Particle Radiotherapy Approach to Treat Irregularly Moving Tumors

Data-driven voluntary body motion detection and non-rigid event-by-event correction for static and dynamic PET

Evaluation of the Accuracy and Robustness of a Motion Correction Algorithm for PET Using a Novel Phantom Approach

Cardiac PET Motion Correction Using Materially Constrained Transform Models

Evaluating an analytical prediction algorithm of positron emitter distributions in patient data for PET monitoring of carbon ion therapy: A simulation study

Analysis methods for in-beam PET images in proton therapy treatment verification: a comparison based on Monte Carlo simulations

A motion model-guided 4D dose reconstruction for pencil beam scanned proton therapy

Impact of respiratory motion on proton pencil beam scanning FLASH radiotherapy: an in silico and phantom measurement study

A simulation study on spatial and time resolution for a cost-effective positron emission particle tracking system

A simulation study of a dual-plate in-room PET system for dose verification in carbon ion therapy

Motion correction for PET using subspace-based real-time MR imaging in simultaneous PET/MR

The impact of motion on onboard MRI-guided pencil beam scanned proton therapy treatments

Quantifying dose uncertainties resulting from cardiorespiratory motion in intensity-modulated proton therapy for cardiac stereotactic body radiotherapy

Motion artifacts occurring at the lung/diaphragm interface using 4D CT attenuation correction of 4D PET scans

Evaluation of In-Beam PET Treatment Verification in Proton Therapy With Different Reconstruction Methods

Non-rigid dual respiratory and cardiac motion correction methods after, during, and before image reconstruction for 4D cardiac PET

Dynamic Cell Imaging in PET With Optimal Transport Regularization

GATE simulation based feasibility studies of in-beam PET monitoring in 12C beam cancer therapy

A Comparison Between Amplitude Sorting And Phase-Angle Sorting Using External Respiratory Measurement For 4d Ct

Impact of Respiratory-gated 4D PET/CT Scan for Motion Correction in Characterizing Lesions Adjacent to the Diaphragm - A Cross-sectional Study at a Tertiary Care Institute